Younger adults · Colorado
Studies for younger adults in Colorado
These studies accept adults from 21 or younger and set an upper age limit of 45 or below, so they are aimed at younger adults. Being in the age range does not mean you qualify; screening decides.
46 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
Studies
- RecruitingHealthy volunteersPhase 1
Use of Pulsatile Intravenous FSH to Mitigate Reprometabolic Syndrome
University of Colorado, Denver
- Location
- Aurora, CO
- Eligibility basics
- Ages 19–37 · Women only
- RecruitingHealthy volunteersPhase 1
Maternal Choline Supplementation and Cannabis Use During Pregnancy: Impact on Early Brain Development
University of Colorado, Denver
- Location
- Aurora, CO
- Eligibility basics
- Ages 18–45 · Women only
- RecruitingPhase 3
A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes
Sanofi
- Location
- Aurora, CO + 33 other US sites
- Eligibility basics
- Ages 1–25
- RecruitingPhase 2
SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes
SAb Biotherapeutics, Inc.
- Location
- Aurora, CO + 20 other US sites
- Eligibility basics
- Ages 5–40
- RecruitingPhase 3
A Study of Baricitinib (LY3009104) to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Diabetes (BARICADE-PRESERVE)
Eli Lilly and Company
- Location
- Aurora, CO + 3 other US sites
- Eligibility basics
- Ages 1–35
- RecruitingPhase 2
Study of MRM-3379 in Male Participants With Fragile X Syndrome (BLOOM)
Mirum Pharmaceuticals, Inc.
- Location
- Aurora, CO + 13 other US sites
- Eligibility basics
- Ages 13–45 · Men only
- RecruitingPhase 3
A Study of Nipocalimab in Pregnancies at Risk for Severe Hemolytic Disease of the Fetus and Newborn (HDFN)
Janssen Research & Development, LLC
- Location
- Aurora, CO + 19 other US sites
- Eligibility basics
- Ages 18–45 · Women only
- RecruitingPhase 3
A Study of Nipocalimab or Intravenous Immunoglobulin (IVIG) in Pregnancies At Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT)
Janssen Research & Development, LLC
- Location
- Aurora, CO + 11 other US sites
- Eligibility basics
- Ages 18–45 · Women only
- RecruitingPhase 3
Study of ALK-001 on the Progression of Stargardt Disease
Alkeus Pharmaceuticals, Inc.
- Location
- Aurora, CO + 11 other US sites
- Eligibility basics
- Ages 8–45
- RecruitingPhase 3
Brexanolone Lifting Outcomes Of Moms
Lipocine Inc.
- Location
- Aurora, CO + 15 other US sites
- Eligibility basics
- Ages 15–45 · Women only
- RecruitingPhase 1/Phase 2
CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)
COUR Pharmaceutical Development Company, Inc.
- Location
- Aurora, CO + 44 other US sites
- Eligibility basics
- Ages 12–35
- RecruitingPhase 3
Study to Assess the Efficacy, Pharmacokinetics, Safety and Tolerability of Iptacopan in Pediatric Patients With Primary IgAN
Novartis Pharmaceuticals
- Location
- Aurora, CO + 4 other US sites
- Eligibility basics
- Ages 2–18
- RecruitingPhase 2
Safety and Efficacy Study of Intracystic TARA-002 for the Treatment of Lymphatic Malformations in Participants 6 Months to Less Than 18 Years of Age
Protara Therapeutics
- Location
- Aurora, CO + 8 other US sites
- Eligibility basics
- Ages 6 mo–18
- RecruitingPhase 3
A Clinical Trial of Elsunersen in Pediatric SCN2A-DEE to Assess Efficacy and Safety
Praxis Precision Medicines
- Location
- Aurora, CO + 5 other US sites
- Eligibility basics
- Ages 0 mo–18
- RecruitingPhase 1/Phase 2
Phase 1/2 Study of MZ-1866, an AAV-9 Gene Therapy Delivered by Intracerebroventricular Injection to Participants With Pitt Hopkins Syndrome
Mahzi Therapeutics
- Location
- Aurora, CO + 2 other US sites
- Eligibility basics
- Ages 2–25
- RecruitingPhase 3
Study of Ravulizumab in Pediatric Participants With Primary IgAN
Alexion Pharmaceuticals, Inc.
- Location
- Aurora, CO
- Eligibility basics
- Ages 2–18
- RecruitingPhase 3
Beeline: A Phase 3 Study in GRIN-related Neurodevelopmental Disorder
GRIN Therapeutics, Inc.
- Location
- Aurora, CO + 15 other US sites
- Eligibility basics
- Ages 1 mo–18
- RecruitingPhase 3
To Investigate the Efficacy of Treatment With Oral NA-921 (Bionetide) Versus Placebo in Females With Rett Syndrome
Biomed Industries, Inc.
- Location
- Aurora, CO + 13 other US sites
- Eligibility basics
- Ages 5–20 · Women only
- RecruitingPhase 3
Fontan Udenafil Exercise Longitudinal Assessment Trial - 2
Mezzion Pharma Co. Ltd
- Location
- Denver, CO + 34 other US sites
- Eligibility basics
- Ages 12–18
- RecruitingHealthy volunteersPhase 2
Long Term Evaluation of Scapular-inserted Contraceptive Implants
Yale University
- Location
- Aurora, CO + 1 other US site
- Eligibility basics
- Ages 18–45 · Women only
- RecruitingHealthy volunteersPhase 4
Etonogestrel Implant as Emergency Contraception
University of Colorado, Denver
- Location
- Aurora, CO
- Eligibility basics
- Ages 18–40 · Women only
- RecruitingHealthy volunteersPhase 2
Convergent Mechanisms Underlying Reprometabolic Syndrome in Women
University of Colorado, Denver
- Location
- Aurora, CO + 1 other US site
- Eligibility basics
- Ages 18–38 · Women only
- RecruitingHealthy volunteersPhase 4
Oral Contraceptive Pill (OCP) Pharmacogenomics
Yale University
- Location
- Aurora, CO + 1 other US site
- Eligibility basics
- Ages 18–45 · Women only
- RecruitingHealthy volunteers
Cannabis Observations on Brain Waves, Retrieval, and Attention: Experiment 4
L. Cinnamon Bidwell
- Location
- Boulder, CO
- Eligibility basics
- Ages 21–40